Skip to main content

Advertisement

Log in

Role of Platelet-Activating Factor in Acid-Induced Esophageal Mucosal Injury

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Studies on the pathophysiology of reflux esophagitis have focused on the associated motility and/or structural abnormalities, with relatively little attention directed to inflammatory mediators involved in the acid-induced mucosal injury. Mast cells line the subepithelial lamina propria in both humans and the opossum model, and are ideally positioned to respond to luminal agents that cross the mucosal barrier. To determine whether certain mast cell mediators are involved in acid-induced mucosal injury, epithelial injury scores following 60 min of luminal perfusion of the opossum esophagus with 100 mM HCl were compared in the presence and absence of two different mast cell stabilizers (disodium cromoglycate and doxantrazole) or the selective platelet-activating factor antagonist TCV-309. In control animals acid perfusion caused release of PAF and significant epithelial injury, characterized by epithelial sloughing and cleft formation. This injury was unaffected by pretreatment with disodium cromoglycate or doxantrazole but was completely prevented by TCV-309 (histology damage score, 2.40±0.28 in controls vs 0.50 ± 0.14 in TCV-309-treated animals). These studies suggest that platelet-activating factor is an important mediator of acid-induced esophageal mucosal damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Orlando RC (2000) Mechanisms of reflux-induced epithelial injuries in the esophagus. Am J Med 108(4A):104S–108S

    Article  PubMed  CAS  Google Scholar 

  2. Ying LTJ, Hurlbut DJ, Paterson WG (1996) Human mucosal mast cell number and relationship to vasculature in acid-induced inflammatory conditions of the esophagus. Can J Gastroenterol 10 (Suppl A):51A

    Google Scholar 

  3. Barclay RL, Dinda PK, Morris GP, Paterson WG (1995) Morphological evidence of mast cell degranulation in an animal model of acid-induced esophageal mucosal injury. Dig Dis Sci 40:1651–1658

    Article  PubMed  CAS  Google Scholar 

  4. Feldman MJ, Morris GP, Dinda PK, Paterson WG (1996) Mast cells mediate acid-induced augmentation of opossum esophageal blood flow via histamine and nitric oxide. Gastroenterology 110:121–128

    Article  PubMed  CAS  Google Scholar 

  5. Paterson WG (1998) Role of mast cell-derived mediators in acid-induced shortening of the esophagus. Am J Physiol 274 (Gastrointest Liver Physiol 37):G385–G388

    PubMed  CAS  Google Scholar 

  6. Paterson WG, Kolyn DM (1994) Esophageal shortening induced by acute intraluminal acid perfusion: a cause for hiatus hernia? Gastroenterology 107:1736–1740

    PubMed  CAS  Google Scholar 

  7. White RJ, Zhang Y, Morris GP, Paterson WG (2001) Esophagitis-related esophageal shortening in opossum is associated with longitudinal muscle hyperresponsiveness. Am J Physiol 280:G463–G469

    CAS  Google Scholar 

  8. Zhang X, Geboes K, Depoortere I, Tack J, Janssens J, Sifrim D (2005) Effect of repeated cycles of acute esophagitis and healing on esophageal peristalsis, tone, and length. Am J Physiol (Gastrointest Liver Physiol) 288(6):G1339–1346

    Google Scholar 

  9. Dunne DP, Paterson WG (2000) Acid-induced oesophageal shortening in humans: a cause for hiatus hernia? Can J Gastroenterol 14:847–850

    PubMed  CAS  Google Scholar 

  10. Izuoka T, Takayama Y, Sugiura T, Taniguchi H, Tamura T, Kitashiro S, Jikuhara T, Iwasaka T (1998) Role of platelet-activating factor on extravascular lung water after coronary reperfusion in dogs. Jpn J Physiol 48(2):157–161

    Article  PubMed  CAS  Google Scholar 

  11. Yamaguchi Y, Matsumura F, Liang J, Okabe K, Matsuda T, Ohshiro H, Ishihara K, Akizuki E, Yamada S, Ogawa M (1999) Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats. Pancreas 18(4):355–363

    Article  PubMed  CAS  Google Scholar 

  12. Poeze M, Froon AH, Ramsay G, Buurman WA, Greve JW (2000) Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group. Shock 14(4):421–428

    Article  PubMed  CAS  Google Scholar 

  13. Zijlstra FK, Hynna-Liepert TT, Dinda PK, Beck IT, Paterson WG (1991) Microvascular permeability increases early in the course of acid-induced esophageal injury. Gastroenterology 101:295–302

    PubMed  CAS  Google Scholar 

  14. Cheng L, Cao W, Fiocchi C, Behar J, Biancani P, Harnett KM (2005) Platelet-activating factor and prostaglandin E2 impair esophageal Ach release in experimental esophagitis. Am J Physiol Gastrointest Liver Physiol 289(3):G418–G428

    Article  PubMed  CAS  Google Scholar 

  15. Tobey NA, Carson JL, Alkiek RA, Orlando RC (1996) Dilated intercellular spaces: a morphological feature of acid-reflux damaged human esophageal epithelium. Gastroeneterology 111:1200–1205

    Article  CAS  Google Scholar 

  16. Morgan GP, Williams JG (1994) Inflammatory mediators in the oesophagus. Gut 35:297–298

    PubMed  CAS  Google Scholar 

  17. Northway MG, Libshitz HI, Osborne BM, Feldman MS, Mamel JJ, West JH, Szwarc IA (1980) Radiation esophagitis in the opossum: radioprotection with indomethacin. Gastroenterology 78:883–892

    PubMed  CAS  Google Scholar 

  18. Harmon JW, Johnson LF, Maydonovitch CL (1980) Effects of 16, 16-dimethyl PGE2 on bile-induced increases in H+ permeability of rabbit esophagus. Adv Prostagland Thrombox Res 8:1577–1579

    CAS  Google Scholar 

  19. Eastwood GL, Beck BD, Castell DO, Brown FC, Fletcher JR (1981) Beneficial effect of indomethacin on acid-induced esophagitis in cats. Dig Dis Sci 26:601–608

    Article  PubMed  CAS  Google Scholar 

  20. Ottignon Y, Alber D, Moussard C, Deschamps JP, Carayon P, Henry JC (1987) Esophageal mucosal prostaglandin E2 levels in health and in gastroesophageal reflux disease. Prostagland Leukotrienes Med 29:141–151

    Article  CAS  Google Scholar 

  21. Stein BE, Schwartzman ML, Carroll MA (1989) Role of arachidonic acid metabolites in acid-peptic injury to rabbit esophagus. Gastroenterology 97:278–283

    PubMed  CAS  Google Scholar 

  22. Lanas A, Jimenez P, Ferrandez A, Escartin A, Arenas J, Esteva F, Ortego J (2003) Selective COX-2 inhibition is associated with decreased mucosal damage induced by acid and pepsin in rabbit esophagitis. Inflammation 27(1):21–29

    Article  PubMed  CAS  Google Scholar 

  23. Opal S, Laterre PF, Abraham E, Francois B, Wittebole X, Lowry S, Dhainaut JF, Warren B, Dugernier T, Lopez A, Sanchez M, Demeyer I, Jauregui L, Lorente JA, McGee W, Reinhart K, Kljucar S, Souza S, Pribble J, Controlled Mortality Trial of Platelet-Activating Factor Acetylhydrolase in Severe Sepsis Investigators (2004) Recombinant human platelet–activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial. Crit Care Med 32:332–341

    Article  PubMed  CAS  Google Scholar 

  24. Imrie WE, McKay CJ (1999) The possible role of platelet-activating factor antagonist therapy in the management of severe acute pancreatitis. Baillieres Best Pract Res Clin Gastroenterol 13(2):357–364

    Article  PubMed  CAS  Google Scholar 

  25. Ewer AK (2002) Role of platelet-activating factor in the pathophysiology of necrotizing enterocolitis. Acta Paediatr Suppl 91(437):2–5

    Article  PubMed  CAS  Google Scholar 

  26. Kubes P, Ibbotson G, Russell J, Wallace JL, Granger DN (1990) Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. Am J Physiol 259(2; Pt 1):G300–G305

    PubMed  CAS  Google Scholar 

  27. Wallace JL, Hogaboam CM, McKnight GW (1990) Platelet-activating factor mediates gastric damage induced by hemorrhagic shock. Am J Physiol 259(1; Pt 1):G140–G146

    PubMed  CAS  Google Scholar 

  28. Konturek SJ, Brzozowksi T (1991) Role of leukotrienes and platelet-activating factor in gastric mucosal damage repair. J Physiol Pharmacol 42(2):107–133

    PubMed  CAS  Google Scholar 

  29. Cheng L, Cao W, Fiocchi C, Behar J, Biancani P, Harnett KM (2006) HCl-induced inflammatory mediators in cat esophageal mucosa and inflammatory mediators in esophageal circular muscle in an in vitro model of esophagitis. Am J Physiol (Gastrointest Liver Physiol), 290(6):G1307–G1317

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W. G. Paterson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paterson, W.G., Kieffer, C.A., Feldman, M.J. et al. Role of Platelet-Activating Factor in Acid-Induced Esophageal Mucosal Injury. Dig Dis Sci 52, 1861–1866 (2007). https://doi.org/10.1007/s10620-006-9385-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9385-9

Keywords

Navigation